
|Articles|July 1, 2003
Tailoring Tx to Disease Stage
San Francisco - When treating cutaneous T-cell lymphoma (CTCL), dermatologists will want to tailor their treatment to the stage of the disease, according to Madeleine Duvic, M.D., who spoke at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Ruxolitinib’s Role in Sustained Vitiligo Management
2
Clinical Tips for Managing Moderate to Severe Psoriasis With Systemics
3
FDA Issues Warnings to Websites Illegally Marketing Botox and Related Products
4
DermaSensor Increases Confidence and Accuracy in Melanoma Detection
5




















